G Medical Innovations Holdings Ltd (GMVDF)

GMVDF Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019
Net Income	13.52	14.46	12.54	15.01
Depreciation & Amortization	1.21	1.36	1.42	2.87
Share-Based Compensation	12.49	0.65	2.87	1.56
Other Operating Activities	-45.7	-27.96	-21.47	-25.74
Operating Cash Flow	-18.48	-11.49	-4.65	-6.3
Capital Expenditures	-2.09	-0.48	-0.51	-0.43
Other Investing Activities	-0.04	0.47	0.05	-
Investing Cash Flow	-2.12	-0.02	-0.46	-0.43
Share Issuance / Repurchase	5.32	13.42	8.99	0
Debt Issued / Paid	9.54	3.85	-3.61	4.1
Financing Cash Flow	14.86	17.27	5.38	4.1
Exchange Rate Effect	0	0	0	-0.01
Net Cash Flow	-5.74	5.76	0.28	-2.62
Free Cash Flow	-20.57	-11.98	-5.15	-6.73
Free Cash Flow Margin	-465.32%	-241.44%	-105.18%	-121.72%
Free Cash Flow Per Share	-28.53	-36.92	-24.54	-1.56

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).